Auto saved by Logseq

pages/STOP2030___Viaje a Ghana 2023.md

@@ -36,14 +36,14 @@ date:: [[2023/12]]
 				- All/ [[Mundo Sano]] facilitate
 					- Circulate and review materials from past MDA and/or relevant trials from communications/social mobilization (GHS has already circulated)
 					- Align on targeted changes for Ghana and for Kenya (meeting with [[KEMRI]] scheduled for [[2024/12/19]]  with the Comms team)
-					- Consider how to reflect non-STH diseases also addressed by the FDC (e.g. [[Onchocercosis]] , Limphatic Filariasis, Scabies). This was consulted with the Comms team an we are not sure it is a good idea. Perhaps we can think about doing posters and material to be left to the sites after the project, but not during the study, to avoid confussion.
+					- Consider how to reflect non-STH diseases also addressed by the FDC (e.g. [[Onchocercosis]], [[Limphatic Filariasis]], [[Scabies]]). This was consulted with the Comms team and we are not sure it is a good idea. Perhaps we can think about doing posters and material to be left to the sites after the project, but not during the study, to avoid confussion.
 					- Materials for Ghana (posters on STH) will be developed in collaboration with GHS to be used in awareness campaigns before the study.
 				- Develop timeline/work plan for activities up to the trial
 					- Ghana
 					- Kenya
 	- ### WP 4 - Acceptability & adherence & feasability - Ivy leads
 		- Target protocol implementation: end 2024 or early 2025 (rainy season permitting) for implementation.
-			- Standalone; not part of the Safety and Effectiveness clinical trial
+			- Standalone; *not part of the Safety and Effectiveness clinical trial*
 		- Protocol
 			- January: Draft primary and secondary research questions aligned to government/programme decision requirements
 			- Full draft protocol Q1 2024 (after formative research)